Literature DB >> 30544348

Laminectomy alone versus fusion for grade 1 lumbar spondylolisthesis in 426 patients from the prospective Quality Outcomes Database.

Andrew K Chan1, Erica F Bisson2, Mohamad Bydon3, Steven D Glassman4, Kevin T Foley5, Eric A Potts6, Christopher I Shaffrey7, Mark E Shaffrey7, Domagoj Coric8, John J Knightly9, Paul Park10, Michael Y Wang11, Kai-Ming Fu12, Jonathan R Slotkin13, Anthony L Asher8, Michael S Virk12, Panagiotis Kerezoudis3, Silky Chotai14, Anthony M DiGiorgio1, Regis W Haid15, Praveen V Mummaneni1.   

Abstract

OBJECTIVEThe AANS launched the Quality Outcomes Database (QOD), a prospective longitudinal registry that includes demographic, clinical, and patient-reported outcome (PRO) data to measure the safety and quality of spine surgery. Registry data offer "real-world" insights into the utility of spinal fusion and decompression surgery for lumbar spondylolisthesis. Using the QOD, the authors compared the initial 12-month outcome data for patients undergoing fusion and those undergoing laminectomy alone for grade 1 degenerative lumbar spondylolisthesis.METHODSData from 12 top enrolling sites were analyzed and 426 patients undergoing elective single-level spine surgery for degenerative grade 1 lumbar spondylolisthesis were found. Baseline, 3-month, and 12-month follow-up data were collected and compared, including baseline clinical characteristics, readmission rates, reoperation rates, and PROs. The PROs included Oswestry Disability Index (ODI), back and leg pain numeric rating scale (NRS) scores, and EuroQol-5 Dimensions health survey (EQ-5D) results.RESULTSA total of 342 (80.3%) patients underwent fusion, with the remaining 84 (19.7%) undergoing decompression alone. The fusion cohort was younger (60.7 vs 69.9 years, p < 0.001), had a higher mean body mass index (31.0 vs 28.4, p < 0.001), and had a greater proportion of patients with back pain as a major component of their initial presentation (88.0% vs 60.7%, p < 0.001). There were no differences in 12-month reoperation rate (4.4% vs 6.0%, p = 0.93) and 3-month readmission rates (3.5% vs 1.2%, p = 0.45). At 12 months, both cohorts improved significantly with regard to ODI, NRS back and leg pain, and EQ-5D (p < 0.001, all comparisons). In adjusted analysis, fusion procedures were associated with superior 12-month ODI (β -4.79, 95% CI -9.28 to -0.31; p = 0.04).CONCLUSIONSSurgery for grade 1 lumbar spondylolisthesis-regardless of treatment strategy-was associated with significant improvements in disability, back and leg pain, and quality of life at 12 months. When adjusting for covariates, fusion surgery was associated with superior ODI at 12 months. Although fusion procedures were associated with a lower rate of reoperation, there was no statistically significant difference at 12 months. Further study must be undertaken to assess the durability of either surgical strategy in longer-term follow-up.

Entities:  

Keywords:  BMI = body mass index; EQ-5D = EuroQol–5 Dimensions health survey; MCID = minimum clinically important difference; MIS = minimally invasive surgery; NRS = numeric rating scale; ODI = Oswestry Disability Index; PRO = patient-reported outcome; QOD = Quality Outcomes Database; Quality Outcomes Database; SLIP = Spinal Laminectomy versus Instrumented Pedicle Screw; SPORT = Spine Patient Outcomes Research Trial; fusion; laminectomy; lumbar; spondylolisthesis

Mesh:

Year:  2018        PMID: 30544348     DOI: 10.3171/2018.8.SPINE17913

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  8 in total

1.  Decompression Alone Compared to Decompression With Fusion in Patients With Lumbar Spondylolisthesis: Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Raymond Pranata; Michael Anthonius Lim; Rachel Vania; Tjokorda Gde Bagus Mahadewa
Journal:  Int J Spine Surg       Date:  2022-02

2.  Effect of MED-TLIF Combined with Percutaneous Pedicle Screw Fixation on Function and Spinal Pelvic Parameters in Patients with Lumbar Spondylolisthesis.

Authors:  Huiqiang Lv; Hailiang Bi; Jianming Wei; Bin Xia
Journal:  Emerg Med Int       Date:  2022-05-20       Impact factor: 1.621

3.  Flexion-extension standing radiographs underestimate instability in patients with single-level lumbar spondylolisthesis: comparing flexion-supine imaging may be more appropriate.

Authors:  Nathan J Lee; Justin Mathew; Jun S Kim; Joseph M Lombardi; Andrew C Vivas; Jay Reidler; Scott L Zuckerman; Paul J Park; Eric Leung; Meghan Cerpa; Mark Weidenbaum; Lawrence G Lenke; Ronald A Lehman; Zeeshan M Sardar
Journal:  J Spine Surg       Date:  2021-03

4.  Evaluation of the Predictors for Unfavorable Clinical Outcomes of Degenerative Lumbar Spondylolisthesis After Lumbar Interbody Fusion Using Machine Learning.

Authors:  Shengtao Dong; Yinghui Zhu; Hua Yang; Ningyu Tang; Guangyi Huang; Jie Li; Kang Tian
Journal:  Front Public Health       Date:  2022-03-03

5.  Decompression alone or decompression and fusion in degenerative lumbar spondylolisthesis.

Authors:  Fei-Long Wei; Cheng-Pei Zhou; Quan-You Gao; Ming-Rui Du; Hao-Ran Gao; Kai-Long Zhu; Tian Li; Ji-Xian Qian; Xiao-Dong Yan
Journal:  EClinicalMedicine       Date:  2022-07-16

6.  Feasibility and Assessment of a Machine Learning-Based Predictive Model of Outcome After Lumbar Decompression Surgery.

Authors:  Arthur André; Bruno Peyrou; Alexandre Carpentier; Jean-Jacques Vignaux
Journal:  Global Spine J       Date:  2020-11-19

7.  Thirty- and 90-day Readmissions After Spinal Surgery for Spine Metastases: A National Trend Analysis of 4423 Patients.

Authors:  Aladine A Elsamadicy; Andrew B Koo; Wyatt B David; Cheryl K Zogg; Adam J Kundishora; Christopher S Hong; Gregory A Kuzmik; Ramana Gorrepati; Pedro O Coutinho; Luis Kolb; Maxwell Laurans; Khalid Abbed
Journal:  Spine (Phila Pa 1976)       Date:  2021-06-15       Impact factor: 3.241

8.  CORR Insights®: What Are the Patient-reported Outcomes, Complications, and Radiographic Results of Lumbar Fusion for Degenerative Spondylolisthesis in Patients Younger Than 50 Years?

Authors:  Charles A Reitman
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.